Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

被引：0
|
作者：
Timothy Wigal
Matthew Brams
Maria Gasior
Joseph Gao
Liza Squires
John Giblin
机构：
[1] Irvine,Department of Pediatrics, University of California
[2] Child Development Center,Private Practice
[3] Bayou City Research,Global Clinical Medicine
[4] Shire Development Inc.,undefined
[5] Biostats,undefined
[6] Shire Development Inc.,undefined
[7] Clinical Study Centers,undefined
[8] LLC,undefined
来源：
Behavioral and Brain Functions | / 6卷
关键词：
ADHD Symptom; Lisdexamfetamine; Clinical Global Impression; Crossover Phase; Lisdexamfetamine Dimesylate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 38 条
  • [1] Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder
    Patrick T. Martin
    Mary Corcoran
    Pinggao Zhang
    Alain Katic
    Clinical Drug Investigation, 2014, 34 : 147 - 157
  • [2] Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study
    Thomas Babcock
    Bryan Dirks
    Ben Adeyi
    Brian Scheckner
    BMC Pharmacology and Toxicology, 13
  • [3] Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study
    Babcock, Thomas
    Dirks, Bryan
    Adeyi, Ben
    Scheckner, Brian
    BMC PHARMACOLOGY & TOXICOLOGY, 2012, 13
  • [4] Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in College Students With ADHD
    DuPaul, George J.
    Weyandt, Lisa L.
    Rossi, Joseph S.
    Vilardo, Brigid A.
    O'Dell, Sean M.
    Carson, Kristen M.
    Verdi, Genevieve
    Swentosky, Anthony
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (03) : 202 - 220
  • [5] Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study
    Ralf W. Dittmann
    Esther Cardo
    Peter Nagy
    Colleen S. Anderson
    Ralph Bloomfield
    Beatriz Caballero
    Nicholas Higgins
    Paul Hodgkins
    Andrew Lyne
    Richard Civil
    David Coghill
    CNS Drugs, 2013, 27 : 1081 - 1092
  • [6] Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
    Lenard A Adler
    Bryan Dirks
    Patrick Deas
    Aparna Raychaudhuri
    Matthew Dauphin
    Keith Saylor
    Richard Weisler
    BMC Psychiatry, 13
  • [7] Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study
    Adler, Lenard A.
    Dirks, Bryan
    Deas, Patrick
    Raychaudhuri, Aparna
    Dauphin, Matthew
    Saylor, Keith
    Weisler, Richard
    BMC PSYCHIATRY, 2013, 13
  • [8] Treatment Response and Remission in a Double-Blind, Randomized, Head-to-Head Study of Lisdexamfetamine Dimesylate and Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder
    Ralf W. Dittmann
    Esther Cardo
    Peter Nagy
    Colleen S. Anderson
    Ben Adeyi
    Beatriz Caballero
    Paul Hodgkins
    Richard Civil
    David R. Coghill
    CNS Drugs, 2014, 28 : 1059 - 1069
  • [9] Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design
    Coghill, David R.
    Banaschewski, Tobias
    Lecendreux, Michel
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen S.
    Civil, Richard
    Dauphin, Matthew
    Higgins, Nicholas
    Lyne, Andrew
    Gasior, Maria
    Squires, Liza A.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (06) : 647 - 657
  • [10] A Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of Lisdexamfetamine Dimesylate in Adults with Moderate to Severe Binge Eating Disorder
    Hudson, James
    McElroy, Susan
    Ferreira-Cornwell, Celeste
    Radewonuk, Jana
    Gasior, Maria
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S135 - S136
1234